The Record
Friday, July 24, 2026
Top stories
WashU announces new Bristol Myers Squibb collaboration
WashU and Bristol Myers Squibb have formed a multiyear collaboration to advance drug development projects in the neurosciences. WashU medical and research trainees will get to work alongside the company’s scientists.
New approach to designing drugs supercharges cancer medication
WashU Medicine researchers have shown in mice that a technique in which components of anti-cancer drugs are administered separately and assembled in the body is more effective at targeting and shrinking tumors.
Silkworm cultivation predated the Silk Road in southern Central Asia
The silkworm moth, whose caterpillars are used in silk production, may have been brought to southern Central Asia 4,000 years ago — nearly 2,000 years earlier than previously assumed — according to new research from Arts & Sciences.
Social Post of the Week#MeetMeInSt.Louie: the Brickline Greenway |
WashU in the News
The $2 billion question behind Kalshi’s new prediction market
Inc.
New York bill could create nation’s first system for tracking AI-related job layoffs
the national law review
Growing tomatoes without photosynthesis
Offrange
WashU wins first-ever Division III Directors’ Cup
Fox 2 St. Louis
Campus and community news
Studying mice, WashU Medicine researchers have identified communication signals linking skeletal muscle, the brain and brown fat tissue that play an important role in aging. The work could help promote healthier aging.
Three members of the WashU community — Tracey Hermanstyne-Jordan (left), Amanda Pope and Will Werner — have been selected for Focus St. Louis’ 2026-27 cohort of Leadership St. Louis.
Kelley Van Dyck Murphy, Constance Vale and Chandler Ahrens — all architecture faculty at the WashU Sam Fox School — have won a Most Enhanced Award from the Landmarks Association of St. Louis for their work on The Key.
Perspectives
Why the headlines on Ozempic’s potential are easy to misread
Epidemiologist Ziyad Al-Aly, MD, at WashU Medicine, writes an article cutting through the hype about the potential of diabetes and weight-loss drugs such as Ozempic to prevent cancer.
the conversation